CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Lidocaine digital block +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01284296
NCT01284296N/ACompleted
CompareCT.gov

Comparison of Three Methods of Hemoglobin Monitoring in Patients Undergoing Spine or Hip Surgery

University of California, San Francisco·interventional·Posted Jan 26, 2011·Updated May 28, 2012

In Brief

A clinical study evaluating Lidocaine digital block and Masimo SpHb continuous hemoglobin monitor for Digital Block. Completed, enrolled 20 participants across 1 site.

Detailed Summary

This study will further investigate the Masimo SpHb \[FDA Approved\] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDigital Block
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJan 26, 2011
Enrollment StartAug 1, 2010
Primary CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.4 years ago

Interventions

Lidocaine digital blockdrug

One dose of lidocaine 2% injected locally into one finger (2 mls total)

Masimo SpHb continuous hemoglobin monitordevice

Masimo SpHb continuous hemoglobin monitor